Trials / Conditions / Central Neuropathic Pain

Central Neuropathic Pain

13 registered clinical trials studyying Central Neuropathic Pain — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Treating Central Neuropathic Pain With Low Dose Naltrexone for People With Spinal Cord Injury NCT06723561	Medical College of Wisconsin	Phase 2
Active Not Recruiting	Low Intensity Focused Ultrasound Modulation of Thalamic Nuclei for Central Neuropathic Pain. NCT06978764	University of Sao Paulo	Phase 1
Not Yet Recruiting	Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in Ch NCT06422117	Haisco Pharmaceutical Group Co., Ltd.	Phase 3
Unknown	Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Ge NCT06072001	Apurano Pharmaceuticals GmbH	Phase 3
Unknown	Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis NCT06071949	Apurano Pharmaceuticals GmbH	Phase 3
Recruiting	Machine-Learning Based EEG Biomarkers for Personalized Interventions NCT06531317	Institut Guttmann	—
Recruiting	Nitrous Oxide as Treatment for Fibromyalgia NCT05357066	University of Chicago	Phase 2
Unknown	EEG Predictors of Neuropathic Pain in SCI NCT04665492	NHS Greater Glasgow and Clyde	—
Completed	Study of Mirogabalin for Central Neuropathic Pain NCT03901352	Daiichi Sankyo Co., Ltd.	Phase 3
Completed	Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis NCT01324232	Avanir Pharmaceuticals	Phase 2
Completed	Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain NCT00313820	Pfizer's Upjohn has merged with Mylan to form Viatris Inc.	Phase 4
Completed	Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial NCT01435798	Brigham and Women's Hospital	Phase 2
Completed	Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Tria NCT02218203	Brigham and Women's Hospital	Phase 2